Global Peripheral Angioplasty and Stenting Market Growth 2023-2029
The report requires updating with new data and is sent in 48 hours after order is placed.
Angioplasty is a procedure that uses a catheter and a balloon to open up blocked arteries. Stenting happens after angioplasty during which your surgeon inserts a small metal device in the artery. The stent helps keep the artery open and improve blood flow.
LPI (LP Information)' newest research report, the “Peripheral Angioplasty and Stenting Industry Forecast” looks at past sales and reviews total world Peripheral Angioplasty and Stenting sales in 2022, providing a comprehensive analysis by region and market sector of projected Peripheral Angioplasty and Stenting sales for 2023 through 2029. With Peripheral Angioplasty and Stenting sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Peripheral Angioplasty and Stenting industry.
This Insight Report provides a comprehensive analysis of the global Peripheral Angioplasty and Stenting landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Peripheral Angioplasty and Stenting portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms' unique position in an accelerating global Peripheral Angioplasty and Stenting market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Peripheral Angioplasty and Stenting and breaks down the forecast by type, by application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Peripheral Angioplasty and Stenting.
The global Peripheral Angioplasty and Stenting market size is projected to grow from US$ million in 2022 to US$ million in 2029; it is expected to grow at a CAGR of % from 2023 to 2029.
United States market for Peripheral Angioplasty and Stenting is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
China market for Peripheral Angioplasty and Stenting is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
Europe market for Peripheral Angioplasty and Stenting is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
Global key Peripheral Angioplasty and Stenting players cover B. Braun, Medtronic, Boston Scientific, BD, Yinyi, Philips, Eurocor, Aachen Resonance and Biotronic, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2022.
This report presents a comprehensive overview, market shares, and growth opportunities of Peripheral Angioplasty and Stenting market by product type, application, key manufacturers and key regions and countries.
Market Segmentation:
Segmentation by type
What is the 10-year outlook for the global Peripheral Angioplasty and Stenting market?
What factors are driving Peripheral Angioplasty and Stenting market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Peripheral Angioplasty and Stenting market opportunities vary by end market size?
How does Peripheral Angioplasty and Stenting break out type, application?
What are the influences of COVID-19 and Russia-Ukraine war?
Angioplasty is a procedure that uses a catheter and a balloon to open up blocked arteries. Stenting happens after angioplasty during which your surgeon inserts a small metal device in the artery. The stent helps keep the artery open and improve blood flow.
LPI (LP Information)' newest research report, the “Peripheral Angioplasty and Stenting Industry Forecast” looks at past sales and reviews total world Peripheral Angioplasty and Stenting sales in 2022, providing a comprehensive analysis by region and market sector of projected Peripheral Angioplasty and Stenting sales for 2023 through 2029. With Peripheral Angioplasty and Stenting sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Peripheral Angioplasty and Stenting industry.
This Insight Report provides a comprehensive analysis of the global Peripheral Angioplasty and Stenting landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Peripheral Angioplasty and Stenting portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms' unique position in an accelerating global Peripheral Angioplasty and Stenting market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Peripheral Angioplasty and Stenting and breaks down the forecast by type, by application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Peripheral Angioplasty and Stenting.
The global Peripheral Angioplasty and Stenting market size is projected to grow from US$ million in 2022 to US$ million in 2029; it is expected to grow at a CAGR of % from 2023 to 2029.
United States market for Peripheral Angioplasty and Stenting is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
China market for Peripheral Angioplasty and Stenting is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
Europe market for Peripheral Angioplasty and Stenting is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
Global key Peripheral Angioplasty and Stenting players cover B. Braun, Medtronic, Boston Scientific, BD, Yinyi, Philips, Eurocor, Aachen Resonance and Biotronic, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2022.
This report presents a comprehensive overview, market shares, and growth opportunities of Peripheral Angioplasty and Stenting market by product type, application, key manufacturers and key regions and countries.
Market Segmentation:
Segmentation by type
- Balloon
- Stent
- Hospitals
- ASCs
- Catheterization Laboratory
- Americas
- United States
- Canada
- Mexico
- Brazil
- APAC
- China
- Japan
- Korea
- Southeast Asia
- India
- Australia
- Europe
- Germany
- France
- UK
- Italy
- Russia
- Middle East & Africa
- Egypt
- South Africa
- Israel
- Turkey
- GCC Countries
- B. Braun
- Medtronic
- Boston Scientific
- BD
- Yinyi
- Philips
- Eurocor
- Aachen Resonance
- Biotronic
What is the 10-year outlook for the global Peripheral Angioplasty and Stenting market?
What factors are driving Peripheral Angioplasty and Stenting market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Peripheral Angioplasty and Stenting market opportunities vary by end market size?
How does Peripheral Angioplasty and Stenting break out type, application?
What are the influences of COVID-19 and Russia-Ukraine war?
1 SCOPE OF THE REPORT
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Peripheral Angioplasty and Stenting Annual Sales 2018-2029
2.1.2 World Current & Future Analysis for Peripheral Angioplasty and Stenting by Geographic Region, 2018, 2022 & 2029
2.1.3 World Current & Future Analysis for Peripheral Angioplasty and Stenting by Country/Region, 2018, 2022 & 2029
2.2 Peripheral Angioplasty and Stenting Segment by Type
2.2.1 Balloon
2.2.2 Stent
2.3 Peripheral Angioplasty and Stenting Sales by Type
2.3.1 Global Peripheral Angioplasty and Stenting Sales Market Share by Type (2018-2023)
2.3.2 Global Peripheral Angioplasty and Stenting Revenue and Market Share by Type (2018-2023)
2.3.3 Global Peripheral Angioplasty and Stenting Sale Price by Type (2018-2023)
2.4 Peripheral Angioplasty and Stenting Segment by Application
2.4.1 Hospitals
2.4.2 ASCs
2.4.3 Catheterization Laboratory
2.5 Peripheral Angioplasty and Stenting Sales by Application
2.5.1 Global Peripheral Angioplasty and Stenting Sale Market Share by Application (2018-2023)
2.5.2 Global Peripheral Angioplasty and Stenting Revenue and Market Share by Application (2018-2023)
2.5.3 Global Peripheral Angioplasty and Stenting Sale Price by Application (2018-2023)
3 GLOBAL PERIPHERAL ANGIOPLASTY AND STENTING BY COMPANY
3.1 Global Peripheral Angioplasty and Stenting Breakdown Data by Company
3.1.1 Global Peripheral Angioplasty and Stenting Annual Sales by Company (2018-2023)
3.1.2 Global Peripheral Angioplasty and Stenting Sales Market Share by Company (2018-2023)
3.2 Global Peripheral Angioplasty and Stenting Annual Revenue by Company (2018-2023)
3.2.1 Global Peripheral Angioplasty and Stenting Revenue by Company (2018-2023)
3.2.2 Global Peripheral Angioplasty and Stenting Revenue Market Share by Company (2018-2023)
3.3 Global Peripheral Angioplasty and Stenting Sale Price by Company
3.4 Key Manufacturers Peripheral Angioplasty and Stenting Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Peripheral Angioplasty and Stenting Product Location Distribution
3.4.2 Players Peripheral Angioplasty and Stenting Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2018-2023)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion
4 WORLD HISTORIC REVIEW FOR PERIPHERAL ANGIOPLASTY AND STENTING BY GEOGRAPHIC REGION
4.1 World Historic Peripheral Angioplasty and Stenting Market Size by Geographic Region (2018-2023)
4.1.1 Global Peripheral Angioplasty and Stenting Annual Sales by Geographic Region (2018-2023)
4.1.2 Global Peripheral Angioplasty and Stenting Annual Revenue by Geographic Region (2018-2023)
4.2 World Historic Peripheral Angioplasty and Stenting Market Size by Country/Region (2018-2023)
4.2.1 Global Peripheral Angioplasty and Stenting Annual Sales by Country/Region (2018-2023)
4.2.2 Global Peripheral Angioplasty and Stenting Annual Revenue by Country/Region (2018-2023)
4.3 Americas Peripheral Angioplasty and Stenting Sales Growth
4.4 APAC Peripheral Angioplasty and Stenting Sales Growth
4.5 Europe Peripheral Angioplasty and Stenting Sales Growth
4.6 Middle East & Africa Peripheral Angioplasty and Stenting Sales Growth
5 AMERICAS
5.1 Americas Peripheral Angioplasty and Stenting Sales by Country
5.1.1 Americas Peripheral Angioplasty and Stenting Sales by Country (2018-2023)
5.1.2 Americas Peripheral Angioplasty and Stenting Revenue by Country (2018-2023)
5.2 Americas Peripheral Angioplasty and Stenting Sales by Type
5.3 Americas Peripheral Angioplasty and Stenting Sales by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Peripheral Angioplasty and Stenting Sales by Region
6.1.1 APAC Peripheral Angioplasty and Stenting Sales by Region (2018-2023)
6.1.2 APAC Peripheral Angioplasty and Stenting Revenue by Region (2018-2023)
6.2 APAC Peripheral Angioplasty and Stenting Sales by Type
6.3 APAC Peripheral Angioplasty and Stenting Sales by Application
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 EUROPE
7.1 Europe Peripheral Angioplasty and Stenting by Country
7.1.1 Europe Peripheral Angioplasty and Stenting Sales by Country (2018-2023)
7.1.2 Europe Peripheral Angioplasty and Stenting Revenue by Country (2018-2023)
7.2 Europe Peripheral Angioplasty and Stenting Sales by Type
7.3 Europe Peripheral Angioplasty and Stenting Sales by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Peripheral Angioplasty and Stenting by Country
8.1.1 Middle East & Africa Peripheral Angioplasty and Stenting Sales by Country (2018-2023)
8.1.2 Middle East & Africa Peripheral Angioplasty and Stenting Revenue by Country (2018-2023)
8.2 Middle East & Africa Peripheral Angioplasty and Stenting Sales by Type
8.3 Middle East & Africa Peripheral Angioplasty and Stenting Sales by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 MANUFACTURING COST STRUCTURE ANALYSIS
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Peripheral Angioplasty and Stenting
10.3 Manufacturing Process Analysis of Peripheral Angioplasty and Stenting
10.4 Industry Chain Structure of Peripheral Angioplasty and Stenting
11 MARKETING, DISTRIBUTORS AND CUSTOMER
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Peripheral Angioplasty and Stenting Distributors
11.3 Peripheral Angioplasty and Stenting Customer
12 WORLD FORECAST REVIEW FOR PERIPHERAL ANGIOPLASTY AND STENTING BY GEOGRAPHIC REGION
12.1 Global Peripheral Angioplasty and Stenting Market Size Forecast by Region
12.1.1 Global Peripheral Angioplasty and Stenting Forecast by Region (2024-2029)
12.1.2 Global Peripheral Angioplasty and Stenting Annual Revenue Forecast by Region (2024-2029)
12.2 Americas Forecast by Country
12.3 APAC Forecast by Region
12.4 Europe Forecast by Country
12.5 Middle East & Africa Forecast by Country
12.6 Global Peripheral Angioplasty and Stenting Forecast by Type
12.7 Global Peripheral Angioplasty and Stenting Forecast by Application
13 KEY PLAYERS ANALYSIS
13.1 B. Braun
13.1.1 B. Braun Company Information
13.1.2 B. Braun Peripheral Angioplasty and Stenting Product Portfolios and Specifications
13.1.3 B. Braun Peripheral Angioplasty and Stenting Sales, Revenue, Price and Gross Margin (2018-2023)
13.1.4 B. Braun Main Business Overview
13.1.5 B. Braun Latest Developments
13.2 Medtronic
13.2.1 Medtronic Company Information
13.2.2 Medtronic Peripheral Angioplasty and Stenting Product Portfolios and Specifications
13.2.3 Medtronic Peripheral Angioplasty and Stenting Sales, Revenue, Price and Gross Margin (2018-2023)
13.2.4 Medtronic Main Business Overview
13.2.5 Medtronic Latest Developments
13.3 Boston Scientific
13.3.1 Boston Scientific Company Information
13.3.2 Boston Scientific Peripheral Angioplasty and Stenting Product Portfolios and Specifications
13.3.3 Boston Scientific Peripheral Angioplasty and Stenting Sales, Revenue, Price and Gross Margin (2018-2023)
13.3.4 Boston Scientific Main Business Overview
13.3.5 Boston Scientific Latest Developments
13.4 BD
13.4.1 BD Company Information
13.4.2 BD Peripheral Angioplasty and Stenting Product Portfolios and Specifications
13.4.3 BD Peripheral Angioplasty and Stenting Sales, Revenue, Price and Gross Margin (2018-2023)
13.4.4 BD Main Business Overview
13.4.5 BD Latest Developments
13.5 Yinyi
13.5.1 Yinyi Company Information
13.5.2 Yinyi Peripheral Angioplasty and Stenting Product Portfolios and Specifications
13.5.3 Yinyi Peripheral Angioplasty and Stenting Sales, Revenue, Price and Gross Margin (2018-2023)
13.5.4 Yinyi Main Business Overview
13.5.5 Yinyi Latest Developments
13.6 Philips
13.6.1 Philips Company Information
13.6.2 Philips Peripheral Angioplasty and Stenting Product Portfolios and Specifications
13.6.3 Philips Peripheral Angioplasty and Stenting Sales, Revenue, Price and Gross Margin (2018-2023)
13.6.4 Philips Main Business Overview
13.6.5 Philips Latest Developments
13.7 Eurocor
13.7.1 Eurocor Company Information
13.7.2 Eurocor Peripheral Angioplasty and Stenting Product Portfolios and Specifications
13.7.3 Eurocor Peripheral Angioplasty and Stenting Sales, Revenue, Price and Gross Margin (2018-2023)
13.7.4 Eurocor Main Business Overview
13.7.5 Eurocor Latest Developments
13.8 Aachen Resonance
13.8.1 Aachen Resonance Company Information
13.8.2 Aachen Resonance Peripheral Angioplasty and Stenting Product Portfolios and Specifications
13.8.3 Aachen Resonance Peripheral Angioplasty and Stenting Sales, Revenue, Price and Gross Margin (2018-2023)
13.8.4 Aachen Resonance Main Business Overview
13.8.5 Aachen Resonance Latest Developments
13.9 Biotronic
13.9.1 Biotronic Company Information
13.9.2 Biotronic Peripheral Angioplasty and Stenting Product Portfolios and Specifications
13.9.3 Biotronic Peripheral Angioplasty and Stenting Sales, Revenue, Price and Gross Margin (2018-2023)
13.9.4 Biotronic Main Business Overview
13.9.5 Biotronic Latest Developments
14 RESEARCH FINDINGS AND CONCLUSION
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Peripheral Angioplasty and Stenting Annual Sales 2018-2029
2.1.2 World Current & Future Analysis for Peripheral Angioplasty and Stenting by Geographic Region, 2018, 2022 & 2029
2.1.3 World Current & Future Analysis for Peripheral Angioplasty and Stenting by Country/Region, 2018, 2022 & 2029
2.2 Peripheral Angioplasty and Stenting Segment by Type
2.2.1 Balloon
2.2.2 Stent
2.3 Peripheral Angioplasty and Stenting Sales by Type
2.3.1 Global Peripheral Angioplasty and Stenting Sales Market Share by Type (2018-2023)
2.3.2 Global Peripheral Angioplasty and Stenting Revenue and Market Share by Type (2018-2023)
2.3.3 Global Peripheral Angioplasty and Stenting Sale Price by Type (2018-2023)
2.4 Peripheral Angioplasty and Stenting Segment by Application
2.4.1 Hospitals
2.4.2 ASCs
2.4.3 Catheterization Laboratory
2.5 Peripheral Angioplasty and Stenting Sales by Application
2.5.1 Global Peripheral Angioplasty and Stenting Sale Market Share by Application (2018-2023)
2.5.2 Global Peripheral Angioplasty and Stenting Revenue and Market Share by Application (2018-2023)
2.5.3 Global Peripheral Angioplasty and Stenting Sale Price by Application (2018-2023)
3 GLOBAL PERIPHERAL ANGIOPLASTY AND STENTING BY COMPANY
3.1 Global Peripheral Angioplasty and Stenting Breakdown Data by Company
3.1.1 Global Peripheral Angioplasty and Stenting Annual Sales by Company (2018-2023)
3.1.2 Global Peripheral Angioplasty and Stenting Sales Market Share by Company (2018-2023)
3.2 Global Peripheral Angioplasty and Stenting Annual Revenue by Company (2018-2023)
3.2.1 Global Peripheral Angioplasty and Stenting Revenue by Company (2018-2023)
3.2.2 Global Peripheral Angioplasty and Stenting Revenue Market Share by Company (2018-2023)
3.3 Global Peripheral Angioplasty and Stenting Sale Price by Company
3.4 Key Manufacturers Peripheral Angioplasty and Stenting Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Peripheral Angioplasty and Stenting Product Location Distribution
3.4.2 Players Peripheral Angioplasty and Stenting Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2018-2023)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion
4 WORLD HISTORIC REVIEW FOR PERIPHERAL ANGIOPLASTY AND STENTING BY GEOGRAPHIC REGION
4.1 World Historic Peripheral Angioplasty and Stenting Market Size by Geographic Region (2018-2023)
4.1.1 Global Peripheral Angioplasty and Stenting Annual Sales by Geographic Region (2018-2023)
4.1.2 Global Peripheral Angioplasty and Stenting Annual Revenue by Geographic Region (2018-2023)
4.2 World Historic Peripheral Angioplasty and Stenting Market Size by Country/Region (2018-2023)
4.2.1 Global Peripheral Angioplasty and Stenting Annual Sales by Country/Region (2018-2023)
4.2.2 Global Peripheral Angioplasty and Stenting Annual Revenue by Country/Region (2018-2023)
4.3 Americas Peripheral Angioplasty and Stenting Sales Growth
4.4 APAC Peripheral Angioplasty and Stenting Sales Growth
4.5 Europe Peripheral Angioplasty and Stenting Sales Growth
4.6 Middle East & Africa Peripheral Angioplasty and Stenting Sales Growth
5 AMERICAS
5.1 Americas Peripheral Angioplasty and Stenting Sales by Country
5.1.1 Americas Peripheral Angioplasty and Stenting Sales by Country (2018-2023)
5.1.2 Americas Peripheral Angioplasty and Stenting Revenue by Country (2018-2023)
5.2 Americas Peripheral Angioplasty and Stenting Sales by Type
5.3 Americas Peripheral Angioplasty and Stenting Sales by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Peripheral Angioplasty and Stenting Sales by Region
6.1.1 APAC Peripheral Angioplasty and Stenting Sales by Region (2018-2023)
6.1.2 APAC Peripheral Angioplasty and Stenting Revenue by Region (2018-2023)
6.2 APAC Peripheral Angioplasty and Stenting Sales by Type
6.3 APAC Peripheral Angioplasty and Stenting Sales by Application
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 EUROPE
7.1 Europe Peripheral Angioplasty and Stenting by Country
7.1.1 Europe Peripheral Angioplasty and Stenting Sales by Country (2018-2023)
7.1.2 Europe Peripheral Angioplasty and Stenting Revenue by Country (2018-2023)
7.2 Europe Peripheral Angioplasty and Stenting Sales by Type
7.3 Europe Peripheral Angioplasty and Stenting Sales by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Peripheral Angioplasty and Stenting by Country
8.1.1 Middle East & Africa Peripheral Angioplasty and Stenting Sales by Country (2018-2023)
8.1.2 Middle East & Africa Peripheral Angioplasty and Stenting Revenue by Country (2018-2023)
8.2 Middle East & Africa Peripheral Angioplasty and Stenting Sales by Type
8.3 Middle East & Africa Peripheral Angioplasty and Stenting Sales by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 MANUFACTURING COST STRUCTURE ANALYSIS
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Peripheral Angioplasty and Stenting
10.3 Manufacturing Process Analysis of Peripheral Angioplasty and Stenting
10.4 Industry Chain Structure of Peripheral Angioplasty and Stenting
11 MARKETING, DISTRIBUTORS AND CUSTOMER
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Peripheral Angioplasty and Stenting Distributors
11.3 Peripheral Angioplasty and Stenting Customer
12 WORLD FORECAST REVIEW FOR PERIPHERAL ANGIOPLASTY AND STENTING BY GEOGRAPHIC REGION
12.1 Global Peripheral Angioplasty and Stenting Market Size Forecast by Region
12.1.1 Global Peripheral Angioplasty and Stenting Forecast by Region (2024-2029)
12.1.2 Global Peripheral Angioplasty and Stenting Annual Revenue Forecast by Region (2024-2029)
12.2 Americas Forecast by Country
12.3 APAC Forecast by Region
12.4 Europe Forecast by Country
12.5 Middle East & Africa Forecast by Country
12.6 Global Peripheral Angioplasty and Stenting Forecast by Type
12.7 Global Peripheral Angioplasty and Stenting Forecast by Application
13 KEY PLAYERS ANALYSIS
13.1 B. Braun
13.1.1 B. Braun Company Information
13.1.2 B. Braun Peripheral Angioplasty and Stenting Product Portfolios and Specifications
13.1.3 B. Braun Peripheral Angioplasty and Stenting Sales, Revenue, Price and Gross Margin (2018-2023)
13.1.4 B. Braun Main Business Overview
13.1.5 B. Braun Latest Developments
13.2 Medtronic
13.2.1 Medtronic Company Information
13.2.2 Medtronic Peripheral Angioplasty and Stenting Product Portfolios and Specifications
13.2.3 Medtronic Peripheral Angioplasty and Stenting Sales, Revenue, Price and Gross Margin (2018-2023)
13.2.4 Medtronic Main Business Overview
13.2.5 Medtronic Latest Developments
13.3 Boston Scientific
13.3.1 Boston Scientific Company Information
13.3.2 Boston Scientific Peripheral Angioplasty and Stenting Product Portfolios and Specifications
13.3.3 Boston Scientific Peripheral Angioplasty and Stenting Sales, Revenue, Price and Gross Margin (2018-2023)
13.3.4 Boston Scientific Main Business Overview
13.3.5 Boston Scientific Latest Developments
13.4 BD
13.4.1 BD Company Information
13.4.2 BD Peripheral Angioplasty and Stenting Product Portfolios and Specifications
13.4.3 BD Peripheral Angioplasty and Stenting Sales, Revenue, Price and Gross Margin (2018-2023)
13.4.4 BD Main Business Overview
13.4.5 BD Latest Developments
13.5 Yinyi
13.5.1 Yinyi Company Information
13.5.2 Yinyi Peripheral Angioplasty and Stenting Product Portfolios and Specifications
13.5.3 Yinyi Peripheral Angioplasty and Stenting Sales, Revenue, Price and Gross Margin (2018-2023)
13.5.4 Yinyi Main Business Overview
13.5.5 Yinyi Latest Developments
13.6 Philips
13.6.1 Philips Company Information
13.6.2 Philips Peripheral Angioplasty and Stenting Product Portfolios and Specifications
13.6.3 Philips Peripheral Angioplasty and Stenting Sales, Revenue, Price and Gross Margin (2018-2023)
13.6.4 Philips Main Business Overview
13.6.5 Philips Latest Developments
13.7 Eurocor
13.7.1 Eurocor Company Information
13.7.2 Eurocor Peripheral Angioplasty and Stenting Product Portfolios and Specifications
13.7.3 Eurocor Peripheral Angioplasty and Stenting Sales, Revenue, Price and Gross Margin (2018-2023)
13.7.4 Eurocor Main Business Overview
13.7.5 Eurocor Latest Developments
13.8 Aachen Resonance
13.8.1 Aachen Resonance Company Information
13.8.2 Aachen Resonance Peripheral Angioplasty and Stenting Product Portfolios and Specifications
13.8.3 Aachen Resonance Peripheral Angioplasty and Stenting Sales, Revenue, Price and Gross Margin (2018-2023)
13.8.4 Aachen Resonance Main Business Overview
13.8.5 Aachen Resonance Latest Developments
13.9 Biotronic
13.9.1 Biotronic Company Information
13.9.2 Biotronic Peripheral Angioplasty and Stenting Product Portfolios and Specifications
13.9.3 Biotronic Peripheral Angioplasty and Stenting Sales, Revenue, Price and Gross Margin (2018-2023)
13.9.4 Biotronic Main Business Overview
13.9.5 Biotronic Latest Developments
14 RESEARCH FINDINGS AND CONCLUSION
LIST OF TABLES
Table 1. Peripheral Angioplasty and Stenting Annual Sales CAGR by Geographic Region (2018, 2022 & 2029) & ($ millions)
Table 2. Peripheral Angioplasty and Stenting Annual Sales CAGR by Country/Region (2018, 2022 & 2029) & ($ millions)
Table 3. Major Players of Balloon
Table 4. Major Players of Stent
Table 5. Global Peripheral Angioplasty and Stenting Sales by Type (2018-2023) & (Units)
Table 6. Global Peripheral Angioplasty and Stenting Sales Market Share by Type (2018-2023)
Table 7. Global Peripheral Angioplasty and Stenting Revenue by Type (2018-2023) & ($ million)
Table 8. Global Peripheral Angioplasty and Stenting Revenue Market Share by Type (2018-2023)
Table 9. Global Peripheral Angioplasty and Stenting Sale Price by Type (2018-2023) & (US$/Unit)
Table 10. Global Peripheral Angioplasty and Stenting Sales by Application (2018-2023) & (Units)
Table 11. Global Peripheral Angioplasty and Stenting Sales Market Share by Application (2018-2023)
Table 12. Global Peripheral Angioplasty and Stenting Revenue by Application (2018-2023)
Table 13. Global Peripheral Angioplasty and Stenting Revenue Market Share by Application (2018-2023)
Table 14. Global Peripheral Angioplasty and Stenting Sale Price by Application (2018-2023) & (US$/Unit)
Table 15. Global Peripheral Angioplasty and Stenting Sales by Company (2018-2023) & (Units)
Table 16. Global Peripheral Angioplasty and Stenting Sales Market Share by Company (2018-2023)
Table 17. Global Peripheral Angioplasty and Stenting Revenue by Company (2018-2023) ($ Millions)
Table 18. Global Peripheral Angioplasty and Stenting Revenue Market Share by Company (2018-2023)
Table 19. Global Peripheral Angioplasty and Stenting Sale Price by Company (2018-2023) & (US$/Unit)
Table 20. Key Manufacturers Peripheral Angioplasty and Stenting Producing Area Distribution and Sales Area
Table 21. Players Peripheral Angioplasty and Stenting Products Offered
Table 22. Peripheral Angioplasty and Stenting Concentration Ratio (CR3, CR5 and CR10) & (2018-2023)
Table 23. New Products and Potential Entrants
Table 24. Mergers & Acquisitions, Expansion
Table 25. Global Peripheral Angioplasty and Stenting Sales by Geographic Region (2018-2023) & (Units)
Table 26. Global Peripheral Angioplasty and Stenting Sales Market Share Geographic Region (2018-2023)
Table 27. Global Peripheral Angioplasty and Stenting Revenue by Geographic Region (2018-2023) & ($ millions)
Table 28. Global Peripheral Angioplasty and Stenting Revenue Market Share by Geographic Region (2018-2023)
Table 29. Global Peripheral Angioplasty and Stenting Sales by Country/Region (2018-2023) & (Units)
Table 30. Global Peripheral Angioplasty and Stenting Sales Market Share by Country/Region (2018-2023)
Table 31. Global Peripheral Angioplasty and Stenting Revenue by Country/Region (2018-2023) & ($ millions)
Table 32. Global Peripheral Angioplasty and Stenting Revenue Market Share by Country/Region (2018-2023)
Table 33. Americas Peripheral Angioplasty and Stenting Sales by Country (2018-2023) & (Units)
Table 34. Americas Peripheral Angioplasty and Stenting Sales Market Share by Country (2018-2023)
Table 35. Americas Peripheral Angioplasty and Stenting Revenue by Country (2018-2023) & ($ Millions)
Table 36. Americas Peripheral Angioplasty and Stenting Revenue Market Share by Country (2018-2023)
Table 37. Americas Peripheral Angioplasty and Stenting Sales by Type (2018-2023) & (Units)
Table 38. Americas Peripheral Angioplasty and Stenting Sales by Application (2018-2023) & (Units)
Table 39. APAC Peripheral Angioplasty and Stenting Sales by Region (2018-2023) & (Units)
Table 40. APAC Peripheral Angioplasty and Stenting Sales Market Share by Region (2018-2023)
Table 41. APAC Peripheral Angioplasty and Stenting Revenue by Region (2018-2023) & ($ Millions)
Table 42. APAC Peripheral Angioplasty and Stenting Revenue Market Share by Region (2018-2023)
Table 43. APAC Peripheral Angioplasty and Stenting Sales by Type (2018-2023) & (Units)
Table 44. APAC Peripheral Angioplasty and Stenting Sales by Application (2018-2023) & (Units)
Table 45. Europe Peripheral Angioplasty and Stenting Sales by Country (2018-2023) & (Units)
Table 46. Europe Peripheral Angioplasty and Stenting Sales Market Share by Country (2018-2023)
Table 47. Europe Peripheral Angioplasty and Stenting Revenue by Country (2018-2023) & ($ Millions)
Table 48. Europe Peripheral Angioplasty and Stenting Revenue Market Share by Country (2018-2023)
Table 49. Europe Peripheral Angioplasty and Stenting Sales by Type (2018-2023) & (Units)
Table 50. Europe Peripheral Angioplasty and Stenting Sales by Application (2018-2023) & (Units)
Table 51. Middle East & Africa Peripheral Angioplasty and Stenting Sales by Country (2018-2023) & (Units)
Table 52. Middle East & Africa Peripheral Angioplasty and Stenting Sales Market Share by Country (2018-2023)
Table 53. Middle East & Africa Peripheral Angioplasty and Stenting Revenue by Country (2018-2023) & ($ Millions)
Table 54. Middle East & Africa Peripheral Angioplasty and Stenting Revenue Market Share by Country (2018-2023)
Table 55. Middle East & Africa Peripheral Angioplasty and Stenting Sales by Type (2018-2023) & (Units)
Table 56. Middle East & Africa Peripheral Angioplasty and Stenting Sales by Application (2018-2023) & (Units)
Table 57. Key Market Drivers & Growth Opportunities of Peripheral Angioplasty and Stenting
Table 58. Key Market Challenges & Risks of Peripheral Angioplasty and Stenting
Table 59. Key Industry Trends of Peripheral Angioplasty and Stenting
Table 60. Peripheral Angioplasty and Stenting Raw Material
Table 61. Key Suppliers of Raw Materials
Table 62. Peripheral Angioplasty and Stenting Distributors List
Table 63. Peripheral Angioplasty and Stenting Customer List
Table 64. Global Peripheral Angioplasty and Stenting Sales Forecast by Region (2024-2029) & (Units)
Table 65. Global Peripheral Angioplasty and Stenting Revenue Forecast by Region (2024-2029) & ($ millions)
Table 66. Americas Peripheral Angioplasty and Stenting Sales Forecast by Country (2024-2029) & (Units)
Table 67. Americas Peripheral Angioplasty and Stenting Revenue Forecast by Country (2024-2029) & ($ millions)
Table 68. APAC Peripheral Angioplasty and Stenting Sales Forecast by Region (2024-2029) & (Units)
Table 69. APAC Peripheral Angioplasty and Stenting Revenue Forecast by Region (2024-2029) & ($ millions)
Table 70. Europe Peripheral Angioplasty and Stenting Sales Forecast by Country (2024-2029) & (Units)
Table 71. Europe Peripheral Angioplasty and Stenting Revenue Forecast by Country (2024-2029) & ($ millions)
Table 72. Middle East & Africa Peripheral Angioplasty and Stenting Sales Forecast by Country (2024-2029) & (Units)
Table 73. Middle East & Africa Peripheral Angioplasty and Stenting Revenue Forecast by Country (2024-2029) & ($ millions)
Table 74. Global Peripheral Angioplasty and Stenting Sales Forecast by Type (2024-2029) & (Units)
Table 75. Global Peripheral Angioplasty and Stenting Revenue Forecast by Type (2024-2029) & ($ Millions)
Table 76. Global Peripheral Angioplasty and Stenting Sales Forecast by Application (2024-2029) & (Units)
Table 77. Global Peripheral Angioplasty and Stenting Revenue Forecast by Application (2024-2029) & ($ Millions)
Table 78. B. Braun Basic Information, Peripheral Angioplasty and Stenting Manufacturing Base, Sales Area and Its Competitors
Table 79. B. Braun Peripheral Angioplasty and Stenting Product Portfolios and Specifications
Table 80. B. Braun Peripheral Angioplasty and Stenting Sales (Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 81. B. Braun Main Business
Table 82. B. Braun Latest Developments
Table 83. Medtronic Basic Information, Peripheral Angioplasty and Stenting Manufacturing Base, Sales Area and Its Competitors
Table 84. Medtronic Peripheral Angioplasty and Stenting Product Portfolios and Specifications
Table 85. Medtronic Peripheral Angioplasty and Stenting Sales (Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 86. Medtronic Main Business
Table 87. Medtronic Latest Developments
Table 88. Boston Scientific Basic Information, Peripheral Angioplasty and Stenting Manufacturing Base, Sales Area and Its Competitors
Table 89. Boston Scientific Peripheral Angioplasty and Stenting Product Portfolios and Specifications
Table 90. Boston Scientific Peripheral Angioplasty and Stenting Sales (Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 91. Boston Scientific Main Business
Table 92. Boston Scientific Latest Developments
Table 93. BD Basic Information, Peripheral Angioplasty and Stenting Manufacturing Base, Sales Area and Its Competitors
Table 94. BD Peripheral Angioplasty and Stenting Product Portfolios and Specifications
Table 95. BD Peripheral Angioplasty and Stenting Sales (Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 96. BD Main Business
Table 97. BD Latest Developments
Table 98. Yinyi Basic Information, Peripheral Angioplasty and Stenting Manufacturing Base, Sales Area and Its Competitors
Table 99. Yinyi Peripheral Angioplasty and Stenting Product Portfolios and Specifications
Table 100. Yinyi Peripheral Angioplasty and Stenting Sales (Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 101. Yinyi Main Business
Table 102. Yinyi Latest Developments
Table 103. Philips Basic Information, Peripheral Angioplasty and Stenting Manufacturing Base, Sales Area and Its Competitors
Table 104. Philips Peripheral Angioplasty and Stenting Product Portfolios and Specifications
Table 105. Philips Peripheral Angioplasty and Stenting Sales (Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 106. Philips Main Business
Table 107. Philips Latest Developments
Table 108. Eurocor Basic Information, Peripheral Angioplasty and Stenting Manufacturing Base, Sales Area and Its Competitors
Table 109. Eurocor Peripheral Angioplasty and Stenting Product Portfolios and Specifications
Table 110. Eurocor Peripheral Angioplasty and Stenting Sales (Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 111. Eurocor Main Business
Table 112. Eurocor Latest Developments
Table 113. Aachen Resonance Basic Information, Peripheral Angioplasty and Stenting Manufacturing Base, Sales Area and Its Competitors
Table 114. Aachen Resonance Peripheral Angioplasty and Stenting Product Portfolios and Specifications
Table 115. Aachen Resonance Peripheral Angioplasty and Stenting Sales (Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 116. Aachen Resonance Main Business
Table 117. Aachen Resonance Latest Developments
Table 118. Biotronic Basic Information, Peripheral Angioplasty and Stenting Manufacturing Base, Sales Area and Its Competitors
Table 119. Biotronic Peripheral Angioplasty and Stenting Product Portfolios and Specifications
Table 120. Biotronic Peripheral Angioplasty and Stenting Sales (Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 121. Biotronic Main Business
Table 122. Biotronic Latest Developments
Table 1. Peripheral Angioplasty and Stenting Annual Sales CAGR by Geographic Region (2018, 2022 & 2029) & ($ millions)
Table 2. Peripheral Angioplasty and Stenting Annual Sales CAGR by Country/Region (2018, 2022 & 2029) & ($ millions)
Table 3. Major Players of Balloon
Table 4. Major Players of Stent
Table 5. Global Peripheral Angioplasty and Stenting Sales by Type (2018-2023) & (Units)
Table 6. Global Peripheral Angioplasty and Stenting Sales Market Share by Type (2018-2023)
Table 7. Global Peripheral Angioplasty and Stenting Revenue by Type (2018-2023) & ($ million)
Table 8. Global Peripheral Angioplasty and Stenting Revenue Market Share by Type (2018-2023)
Table 9. Global Peripheral Angioplasty and Stenting Sale Price by Type (2018-2023) & (US$/Unit)
Table 10. Global Peripheral Angioplasty and Stenting Sales by Application (2018-2023) & (Units)
Table 11. Global Peripheral Angioplasty and Stenting Sales Market Share by Application (2018-2023)
Table 12. Global Peripheral Angioplasty and Stenting Revenue by Application (2018-2023)
Table 13. Global Peripheral Angioplasty and Stenting Revenue Market Share by Application (2018-2023)
Table 14. Global Peripheral Angioplasty and Stenting Sale Price by Application (2018-2023) & (US$/Unit)
Table 15. Global Peripheral Angioplasty and Stenting Sales by Company (2018-2023) & (Units)
Table 16. Global Peripheral Angioplasty and Stenting Sales Market Share by Company (2018-2023)
Table 17. Global Peripheral Angioplasty and Stenting Revenue by Company (2018-2023) ($ Millions)
Table 18. Global Peripheral Angioplasty and Stenting Revenue Market Share by Company (2018-2023)
Table 19. Global Peripheral Angioplasty and Stenting Sale Price by Company (2018-2023) & (US$/Unit)
Table 20. Key Manufacturers Peripheral Angioplasty and Stenting Producing Area Distribution and Sales Area
Table 21. Players Peripheral Angioplasty and Stenting Products Offered
Table 22. Peripheral Angioplasty and Stenting Concentration Ratio (CR3, CR5 and CR10) & (2018-2023)
Table 23. New Products and Potential Entrants
Table 24. Mergers & Acquisitions, Expansion
Table 25. Global Peripheral Angioplasty and Stenting Sales by Geographic Region (2018-2023) & (Units)
Table 26. Global Peripheral Angioplasty and Stenting Sales Market Share Geographic Region (2018-2023)
Table 27. Global Peripheral Angioplasty and Stenting Revenue by Geographic Region (2018-2023) & ($ millions)
Table 28. Global Peripheral Angioplasty and Stenting Revenue Market Share by Geographic Region (2018-2023)
Table 29. Global Peripheral Angioplasty and Stenting Sales by Country/Region (2018-2023) & (Units)
Table 30. Global Peripheral Angioplasty and Stenting Sales Market Share by Country/Region (2018-2023)
Table 31. Global Peripheral Angioplasty and Stenting Revenue by Country/Region (2018-2023) & ($ millions)
Table 32. Global Peripheral Angioplasty and Stenting Revenue Market Share by Country/Region (2018-2023)
Table 33. Americas Peripheral Angioplasty and Stenting Sales by Country (2018-2023) & (Units)
Table 34. Americas Peripheral Angioplasty and Stenting Sales Market Share by Country (2018-2023)
Table 35. Americas Peripheral Angioplasty and Stenting Revenue by Country (2018-2023) & ($ Millions)
Table 36. Americas Peripheral Angioplasty and Stenting Revenue Market Share by Country (2018-2023)
Table 37. Americas Peripheral Angioplasty and Stenting Sales by Type (2018-2023) & (Units)
Table 38. Americas Peripheral Angioplasty and Stenting Sales by Application (2018-2023) & (Units)
Table 39. APAC Peripheral Angioplasty and Stenting Sales by Region (2018-2023) & (Units)
Table 40. APAC Peripheral Angioplasty and Stenting Sales Market Share by Region (2018-2023)
Table 41. APAC Peripheral Angioplasty and Stenting Revenue by Region (2018-2023) & ($ Millions)
Table 42. APAC Peripheral Angioplasty and Stenting Revenue Market Share by Region (2018-2023)
Table 43. APAC Peripheral Angioplasty and Stenting Sales by Type (2018-2023) & (Units)
Table 44. APAC Peripheral Angioplasty and Stenting Sales by Application (2018-2023) & (Units)
Table 45. Europe Peripheral Angioplasty and Stenting Sales by Country (2018-2023) & (Units)
Table 46. Europe Peripheral Angioplasty and Stenting Sales Market Share by Country (2018-2023)
Table 47. Europe Peripheral Angioplasty and Stenting Revenue by Country (2018-2023) & ($ Millions)
Table 48. Europe Peripheral Angioplasty and Stenting Revenue Market Share by Country (2018-2023)
Table 49. Europe Peripheral Angioplasty and Stenting Sales by Type (2018-2023) & (Units)
Table 50. Europe Peripheral Angioplasty and Stenting Sales by Application (2018-2023) & (Units)
Table 51. Middle East & Africa Peripheral Angioplasty and Stenting Sales by Country (2018-2023) & (Units)
Table 52. Middle East & Africa Peripheral Angioplasty and Stenting Sales Market Share by Country (2018-2023)
Table 53. Middle East & Africa Peripheral Angioplasty and Stenting Revenue by Country (2018-2023) & ($ Millions)
Table 54. Middle East & Africa Peripheral Angioplasty and Stenting Revenue Market Share by Country (2018-2023)
Table 55. Middle East & Africa Peripheral Angioplasty and Stenting Sales by Type (2018-2023) & (Units)
Table 56. Middle East & Africa Peripheral Angioplasty and Stenting Sales by Application (2018-2023) & (Units)
Table 57. Key Market Drivers & Growth Opportunities of Peripheral Angioplasty and Stenting
Table 58. Key Market Challenges & Risks of Peripheral Angioplasty and Stenting
Table 59. Key Industry Trends of Peripheral Angioplasty and Stenting
Table 60. Peripheral Angioplasty and Stenting Raw Material
Table 61. Key Suppliers of Raw Materials
Table 62. Peripheral Angioplasty and Stenting Distributors List
Table 63. Peripheral Angioplasty and Stenting Customer List
Table 64. Global Peripheral Angioplasty and Stenting Sales Forecast by Region (2024-2029) & (Units)
Table 65. Global Peripheral Angioplasty and Stenting Revenue Forecast by Region (2024-2029) & ($ millions)
Table 66. Americas Peripheral Angioplasty and Stenting Sales Forecast by Country (2024-2029) & (Units)
Table 67. Americas Peripheral Angioplasty and Stenting Revenue Forecast by Country (2024-2029) & ($ millions)
Table 68. APAC Peripheral Angioplasty and Stenting Sales Forecast by Region (2024-2029) & (Units)
Table 69. APAC Peripheral Angioplasty and Stenting Revenue Forecast by Region (2024-2029) & ($ millions)
Table 70. Europe Peripheral Angioplasty and Stenting Sales Forecast by Country (2024-2029) & (Units)
Table 71. Europe Peripheral Angioplasty and Stenting Revenue Forecast by Country (2024-2029) & ($ millions)
Table 72. Middle East & Africa Peripheral Angioplasty and Stenting Sales Forecast by Country (2024-2029) & (Units)
Table 73. Middle East & Africa Peripheral Angioplasty and Stenting Revenue Forecast by Country (2024-2029) & ($ millions)
Table 74. Global Peripheral Angioplasty and Stenting Sales Forecast by Type (2024-2029) & (Units)
Table 75. Global Peripheral Angioplasty and Stenting Revenue Forecast by Type (2024-2029) & ($ Millions)
Table 76. Global Peripheral Angioplasty and Stenting Sales Forecast by Application (2024-2029) & (Units)
Table 77. Global Peripheral Angioplasty and Stenting Revenue Forecast by Application (2024-2029) & ($ Millions)
Table 78. B. Braun Basic Information, Peripheral Angioplasty and Stenting Manufacturing Base, Sales Area and Its Competitors
Table 79. B. Braun Peripheral Angioplasty and Stenting Product Portfolios and Specifications
Table 80. B. Braun Peripheral Angioplasty and Stenting Sales (Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 81. B. Braun Main Business
Table 82. B. Braun Latest Developments
Table 83. Medtronic Basic Information, Peripheral Angioplasty and Stenting Manufacturing Base, Sales Area and Its Competitors
Table 84. Medtronic Peripheral Angioplasty and Stenting Product Portfolios and Specifications
Table 85. Medtronic Peripheral Angioplasty and Stenting Sales (Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 86. Medtronic Main Business
Table 87. Medtronic Latest Developments
Table 88. Boston Scientific Basic Information, Peripheral Angioplasty and Stenting Manufacturing Base, Sales Area and Its Competitors
Table 89. Boston Scientific Peripheral Angioplasty and Stenting Product Portfolios and Specifications
Table 90. Boston Scientific Peripheral Angioplasty and Stenting Sales (Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 91. Boston Scientific Main Business
Table 92. Boston Scientific Latest Developments
Table 93. BD Basic Information, Peripheral Angioplasty and Stenting Manufacturing Base, Sales Area and Its Competitors
Table 94. BD Peripheral Angioplasty and Stenting Product Portfolios and Specifications
Table 95. BD Peripheral Angioplasty and Stenting Sales (Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 96. BD Main Business
Table 97. BD Latest Developments
Table 98. Yinyi Basic Information, Peripheral Angioplasty and Stenting Manufacturing Base, Sales Area and Its Competitors
Table 99. Yinyi Peripheral Angioplasty and Stenting Product Portfolios and Specifications
Table 100. Yinyi Peripheral Angioplasty and Stenting Sales (Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 101. Yinyi Main Business
Table 102. Yinyi Latest Developments
Table 103. Philips Basic Information, Peripheral Angioplasty and Stenting Manufacturing Base, Sales Area and Its Competitors
Table 104. Philips Peripheral Angioplasty and Stenting Product Portfolios and Specifications
Table 105. Philips Peripheral Angioplasty and Stenting Sales (Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 106. Philips Main Business
Table 107. Philips Latest Developments
Table 108. Eurocor Basic Information, Peripheral Angioplasty and Stenting Manufacturing Base, Sales Area and Its Competitors
Table 109. Eurocor Peripheral Angioplasty and Stenting Product Portfolios and Specifications
Table 110. Eurocor Peripheral Angioplasty and Stenting Sales (Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 111. Eurocor Main Business
Table 112. Eurocor Latest Developments
Table 113. Aachen Resonance Basic Information, Peripheral Angioplasty and Stenting Manufacturing Base, Sales Area and Its Competitors
Table 114. Aachen Resonance Peripheral Angioplasty and Stenting Product Portfolios and Specifications
Table 115. Aachen Resonance Peripheral Angioplasty and Stenting Sales (Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 116. Aachen Resonance Main Business
Table 117. Aachen Resonance Latest Developments
Table 118. Biotronic Basic Information, Peripheral Angioplasty and Stenting Manufacturing Base, Sales Area and Its Competitors
Table 119. Biotronic Peripheral Angioplasty and Stenting Product Portfolios and Specifications
Table 120. Biotronic Peripheral Angioplasty and Stenting Sales (Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 121. Biotronic Main Business
Table 122. Biotronic Latest Developments
LIST OF FIGURES
Figure 1. Picture of Peripheral Angioplasty and Stenting
Figure 2. Peripheral Angioplasty and Stenting Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Peripheral Angioplasty and Stenting Sales Growth Rate 2018-2029 (Units)
Figure 7. Global Peripheral Angioplasty and Stenting Revenue Growth Rate 2018-2029 ($ Millions)
Figure 8. Peripheral Angioplasty and Stenting Sales by Region (2018, 2022 & 2029) & ($ Millions)
Figure 9. Product Picture of Balloon
Figure 10. Product Picture of Stent
Figure 11. Global Peripheral Angioplasty and Stenting Sales Market Share by Type in 2022
Figure 12. Global Peripheral Angioplasty and Stenting Revenue Market Share by Type (2018-2023)
Figure 13. Peripheral Angioplasty and Stenting Consumed in Hospitals
Figure 14. Global Peripheral Angioplasty and Stenting Market: Hospitals (2018-2023) & (Units)
Figure 15. Peripheral Angioplasty and Stenting Consumed in ASCs
Figure 16. Global Peripheral Angioplasty and Stenting Market: ASCs (2018-2023) & (Units)
Figure 17. Peripheral Angioplasty and Stenting Consumed in Catheterization Laboratory
Figure 18. Global Peripheral Angioplasty and Stenting Market: Catheterization Laboratory (2018-2023) & (Units)
Figure 19. Global Peripheral Angioplasty and Stenting Sales Market Share by Application (2022)
Figure 20. Global Peripheral Angioplasty and Stenting Revenue Market Share by Application in 2022
Figure 21. Peripheral Angioplasty and Stenting Sales Market by Company in 2022 (Units)
Figure 22. Global Peripheral Angioplasty and Stenting Sales Market Share by Company in 2022
Figure 23. Peripheral Angioplasty and Stenting Revenue Market by Company in 2022 ($ Million)
Figure 24. Global Peripheral Angioplasty and Stenting Revenue Market Share by Company in 2022
Figure 25. Global Peripheral Angioplasty and Stenting Sales Market Share by Geographic Region (2018-2023)
Figure 26. Global Peripheral Angioplasty and Stenting Revenue Market Share by Geographic Region in 2022
Figure 27. Americas Peripheral Angioplasty and Stenting Sales 2018-2023 (Units)
Figure 28. Americas Peripheral Angioplasty and Stenting Revenue 2018-2023 ($ Millions)
Figure 29. APAC Peripheral Angioplasty and Stenting Sales 2018-2023 (Units)
Figure 30. APAC Peripheral Angioplasty and Stenting Revenue 2018-2023 ($ Millions)
Figure 31. Europe Peripheral Angioplasty and Stenting Sales 2018-2023 (Units)
Figure 32. Europe Peripheral Angioplasty and Stenting Revenue 2018-2023 ($ Millions)
Figure 33. Middle East & Africa Peripheral Angioplasty and Stenting Sales 2018-2023 (Units)
Figure 34. Middle East & Africa Peripheral Angioplasty and Stenting Revenue 2018-2023 ($ Millions)
Figure 35. Americas Peripheral Angioplasty and Stenting Sales Market Share by Country in 2022
Figure 36. Americas Peripheral Angioplasty and Stenting Revenue Market Share by Country in 2022
Figure 37. Americas Peripheral Angioplasty and Stenting Sales Market Share by Type (2018-2023)
Figure 38. Americas Peripheral Angioplasty and Stenting Sales Market Share by Application (2018-2023)
Figure 39. United States Peripheral Angioplasty and Stenting Revenue Growth 2018-2023 ($ Millions)
Figure 40. Canada Peripheral Angioplasty and Stenting Revenue Growth 2018-2023 ($ Millions)
Figure 41. Mexico Peripheral Angioplasty and Stenting Revenue Growth 2018-2023 ($ Millions)
Figure 42. Brazil Peripheral Angioplasty and Stenting Revenue Growth 2018-2023 ($ Millions)
Figure 43. APAC Peripheral Angioplasty and Stenting Sales Market Share by Region in 2022
Figure 44. APAC Peripheral Angioplasty and Stenting Revenue Market Share by Regions in 2022
Figure 45. APAC Peripheral Angioplasty and Stenting Sales Market Share by Type (2018-2023)
Figure 46. APAC Peripheral Angioplasty and Stenting Sales Market Share by Application (2018-2023)
Figure 47. China Peripheral Angioplasty and Stenting Revenue Growth 2018-2023 ($ Millions)
Figure 48. Japan Peripheral Angioplasty and Stenting Revenue Growth 2018-2023 ($ Millions)
Figure 49. South Korea Peripheral Angioplasty and Stenting Revenue Growth 2018-2023 ($ Millions)
Figure 50. Southeast Asia Peripheral Angioplasty and Stenting Revenue Growth 2018-2023 ($ Millions)
Figure 51. India Peripheral Angioplasty and Stenting Revenue Growth 2018-2023 ($ Millions)
Figure 52. Australia Peripheral Angioplasty and Stenting Revenue Growth 2018-2023 ($ Millions)
Figure 53. China Taiwan Peripheral Angioplasty and Stenting Revenue Growth 2018-2023 ($ Millions)
Figure 54. Europe Peripheral Angioplasty and Stenting Sales Market Share by Country in 2022
Figure 55. Europe Peripheral Angioplasty and Stenting Revenue Market Share by Country in 2022
Figure 56. Europe Peripheral Angioplasty and Stenting Sales Market Share by Type (2018-2023)
Figure 57. Europe Peripheral Angioplasty and Stenting Sales Market Share by Application (2018-2023)
Figure 58. Germany Peripheral Angioplasty and Stenting Revenue Growth 2018-2023 ($ Millions)
Figure 59. France Peripheral Angioplasty and Stenting Revenue Growth 2018-2023 ($ Millions)
Figure 60. UK Peripheral Angioplasty and Stenting Revenue Growth 2018-2023 ($ Millions)
Figure 61. Italy Peripheral Angioplasty and Stenting Revenue Growth 2018-2023 ($ Millions)
Figure 62. Russia Peripheral Angioplasty and Stenting Revenue Growth 2018-2023 ($ Millions)
Figure 63. Middle East & Africa Peripheral Angioplasty and Stenting Sales Market Share by Country in 2022
Figure 64. Middle East & Africa Peripheral Angioplasty and Stenting Revenue Market Share by Country in 2022
Figure 65. Middle East & Africa Peripheral Angioplasty and Stenting Sales Market Share by Type (2018-2023)
Figure 66. Middle East & Africa Peripheral Angioplasty and Stenting Sales Market Share by Application (2018-2023)
Figure 67. Egypt Peripheral Angioplasty and Stenting Revenue Growth 2018-2023 ($ Millions)
Figure 68. South Africa Peripheral Angioplasty and Stenting Revenue Growth 2018-2023 ($ Millions)
Figure 69. Israel Peripheral Angioplasty and Stenting Revenue Growth 2018-2023 ($ Millions)
Figure 70. Turkey Peripheral Angioplasty and Stenting Revenue Growth 2018-2023 ($ Millions)
Figure 71. GCC Country Peripheral Angioplasty and Stenting Revenue Growth 2018-2023 ($ Millions)
Figure 72. Manufacturing Cost Structure Analysis of Peripheral Angioplasty and Stenting in 2022
Figure 73. Manufacturing Process Analysis of Peripheral Angioplasty and Stenting
Figure 74. Industry Chain Structure of Peripheral Angioplasty and Stenting
Figure 75. Channels of Distribution
Figure 76. Global Peripheral Angioplasty and Stenting Sales Market Forecast by Region (2024-2029)
Figure 77. Global Peripheral Angioplasty and Stenting Revenue Market Share Forecast by Region (2024-2029)
Figure 78. Global Peripheral Angioplasty and Stenting Sales Market Share Forecast by Type (2024-2029)
Figure 79. Global Peripheral Angioplasty and Stenting Revenue Market Share Forecast by Type (2024-2029)
Figure 80. Global Peripheral Angioplasty and Stenting Sales Market Share Forecast by Application (2024-2029)
Figure 81. Global Peripheral Angioplasty and Stenting Revenue Market Share Forecast by Application (2024-2029)
Figure 1. Picture of Peripheral Angioplasty and Stenting
Figure 2. Peripheral Angioplasty and Stenting Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Peripheral Angioplasty and Stenting Sales Growth Rate 2018-2029 (Units)
Figure 7. Global Peripheral Angioplasty and Stenting Revenue Growth Rate 2018-2029 ($ Millions)
Figure 8. Peripheral Angioplasty and Stenting Sales by Region (2018, 2022 & 2029) & ($ Millions)
Figure 9. Product Picture of Balloon
Figure 10. Product Picture of Stent
Figure 11. Global Peripheral Angioplasty and Stenting Sales Market Share by Type in 2022
Figure 12. Global Peripheral Angioplasty and Stenting Revenue Market Share by Type (2018-2023)
Figure 13. Peripheral Angioplasty and Stenting Consumed in Hospitals
Figure 14. Global Peripheral Angioplasty and Stenting Market: Hospitals (2018-2023) & (Units)
Figure 15. Peripheral Angioplasty and Stenting Consumed in ASCs
Figure 16. Global Peripheral Angioplasty and Stenting Market: ASCs (2018-2023) & (Units)
Figure 17. Peripheral Angioplasty and Stenting Consumed in Catheterization Laboratory
Figure 18. Global Peripheral Angioplasty and Stenting Market: Catheterization Laboratory (2018-2023) & (Units)
Figure 19. Global Peripheral Angioplasty and Stenting Sales Market Share by Application (2022)
Figure 20. Global Peripheral Angioplasty and Stenting Revenue Market Share by Application in 2022
Figure 21. Peripheral Angioplasty and Stenting Sales Market by Company in 2022 (Units)
Figure 22. Global Peripheral Angioplasty and Stenting Sales Market Share by Company in 2022
Figure 23. Peripheral Angioplasty and Stenting Revenue Market by Company in 2022 ($ Million)
Figure 24. Global Peripheral Angioplasty and Stenting Revenue Market Share by Company in 2022
Figure 25. Global Peripheral Angioplasty and Stenting Sales Market Share by Geographic Region (2018-2023)
Figure 26. Global Peripheral Angioplasty and Stenting Revenue Market Share by Geographic Region in 2022
Figure 27. Americas Peripheral Angioplasty and Stenting Sales 2018-2023 (Units)
Figure 28. Americas Peripheral Angioplasty and Stenting Revenue 2018-2023 ($ Millions)
Figure 29. APAC Peripheral Angioplasty and Stenting Sales 2018-2023 (Units)
Figure 30. APAC Peripheral Angioplasty and Stenting Revenue 2018-2023 ($ Millions)
Figure 31. Europe Peripheral Angioplasty and Stenting Sales 2018-2023 (Units)
Figure 32. Europe Peripheral Angioplasty and Stenting Revenue 2018-2023 ($ Millions)
Figure 33. Middle East & Africa Peripheral Angioplasty and Stenting Sales 2018-2023 (Units)
Figure 34. Middle East & Africa Peripheral Angioplasty and Stenting Revenue 2018-2023 ($ Millions)
Figure 35. Americas Peripheral Angioplasty and Stenting Sales Market Share by Country in 2022
Figure 36. Americas Peripheral Angioplasty and Stenting Revenue Market Share by Country in 2022
Figure 37. Americas Peripheral Angioplasty and Stenting Sales Market Share by Type (2018-2023)
Figure 38. Americas Peripheral Angioplasty and Stenting Sales Market Share by Application (2018-2023)
Figure 39. United States Peripheral Angioplasty and Stenting Revenue Growth 2018-2023 ($ Millions)
Figure 40. Canada Peripheral Angioplasty and Stenting Revenue Growth 2018-2023 ($ Millions)
Figure 41. Mexico Peripheral Angioplasty and Stenting Revenue Growth 2018-2023 ($ Millions)
Figure 42. Brazil Peripheral Angioplasty and Stenting Revenue Growth 2018-2023 ($ Millions)
Figure 43. APAC Peripheral Angioplasty and Stenting Sales Market Share by Region in 2022
Figure 44. APAC Peripheral Angioplasty and Stenting Revenue Market Share by Regions in 2022
Figure 45. APAC Peripheral Angioplasty and Stenting Sales Market Share by Type (2018-2023)
Figure 46. APAC Peripheral Angioplasty and Stenting Sales Market Share by Application (2018-2023)
Figure 47. China Peripheral Angioplasty and Stenting Revenue Growth 2018-2023 ($ Millions)
Figure 48. Japan Peripheral Angioplasty and Stenting Revenue Growth 2018-2023 ($ Millions)
Figure 49. South Korea Peripheral Angioplasty and Stenting Revenue Growth 2018-2023 ($ Millions)
Figure 50. Southeast Asia Peripheral Angioplasty and Stenting Revenue Growth 2018-2023 ($ Millions)
Figure 51. India Peripheral Angioplasty and Stenting Revenue Growth 2018-2023 ($ Millions)
Figure 52. Australia Peripheral Angioplasty and Stenting Revenue Growth 2018-2023 ($ Millions)
Figure 53. China Taiwan Peripheral Angioplasty and Stenting Revenue Growth 2018-2023 ($ Millions)
Figure 54. Europe Peripheral Angioplasty and Stenting Sales Market Share by Country in 2022
Figure 55. Europe Peripheral Angioplasty and Stenting Revenue Market Share by Country in 2022
Figure 56. Europe Peripheral Angioplasty and Stenting Sales Market Share by Type (2018-2023)
Figure 57. Europe Peripheral Angioplasty and Stenting Sales Market Share by Application (2018-2023)
Figure 58. Germany Peripheral Angioplasty and Stenting Revenue Growth 2018-2023 ($ Millions)
Figure 59. France Peripheral Angioplasty and Stenting Revenue Growth 2018-2023 ($ Millions)
Figure 60. UK Peripheral Angioplasty and Stenting Revenue Growth 2018-2023 ($ Millions)
Figure 61. Italy Peripheral Angioplasty and Stenting Revenue Growth 2018-2023 ($ Millions)
Figure 62. Russia Peripheral Angioplasty and Stenting Revenue Growth 2018-2023 ($ Millions)
Figure 63. Middle East & Africa Peripheral Angioplasty and Stenting Sales Market Share by Country in 2022
Figure 64. Middle East & Africa Peripheral Angioplasty and Stenting Revenue Market Share by Country in 2022
Figure 65. Middle East & Africa Peripheral Angioplasty and Stenting Sales Market Share by Type (2018-2023)
Figure 66. Middle East & Africa Peripheral Angioplasty and Stenting Sales Market Share by Application (2018-2023)
Figure 67. Egypt Peripheral Angioplasty and Stenting Revenue Growth 2018-2023 ($ Millions)
Figure 68. South Africa Peripheral Angioplasty and Stenting Revenue Growth 2018-2023 ($ Millions)
Figure 69. Israel Peripheral Angioplasty and Stenting Revenue Growth 2018-2023 ($ Millions)
Figure 70. Turkey Peripheral Angioplasty and Stenting Revenue Growth 2018-2023 ($ Millions)
Figure 71. GCC Country Peripheral Angioplasty and Stenting Revenue Growth 2018-2023 ($ Millions)
Figure 72. Manufacturing Cost Structure Analysis of Peripheral Angioplasty and Stenting in 2022
Figure 73. Manufacturing Process Analysis of Peripheral Angioplasty and Stenting
Figure 74. Industry Chain Structure of Peripheral Angioplasty and Stenting
Figure 75. Channels of Distribution
Figure 76. Global Peripheral Angioplasty and Stenting Sales Market Forecast by Region (2024-2029)
Figure 77. Global Peripheral Angioplasty and Stenting Revenue Market Share Forecast by Region (2024-2029)
Figure 78. Global Peripheral Angioplasty and Stenting Sales Market Share Forecast by Type (2024-2029)
Figure 79. Global Peripheral Angioplasty and Stenting Revenue Market Share Forecast by Type (2024-2029)
Figure 80. Global Peripheral Angioplasty and Stenting Sales Market Share Forecast by Application (2024-2029)
Figure 81. Global Peripheral Angioplasty and Stenting Revenue Market Share Forecast by Application (2024-2029)
